Thalmann GN - Search Results

1

Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, Kruithof-de Julio M. Manna F, et al. Among authors: thalmann gn. Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):a033688. doi: 10.1101/cshperspect.a033688. Cold Spring Harb Perspect Med. 2019. PMID: 29661810 Free PMC article. Review.

2

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW. Thalmann GN, et al. Cancer Res. 1994 May 15;54(10):2577-81. Cancer Res. 1994. PMID: 8168083

3

Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.

Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW. Thalmann GN, et al. J Natl Cancer Inst. 1996 Jun 19;88(12):794-801. doi: 10.1093/jnci/88.12.794. J Natl Cancer Inst. 1996. PMID: 8637045

4

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.

Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Ko SC, et al. Among authors: thalmann gn. Hum Gene Ther. 1996 Sep 10;7(14):1683-91. doi: 10.1089/hum.1996.7.14-1683. Hum Gene Ther. 1996. PMID: 8886839

5

Osteopontin: possible role in prostate cancer progression.

Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, Farach-Carson CM, Studer UE, Chung LW. Thalmann GN, et al. Clin Cancer Res. 1999 Aug;5(8):2271-7. Clin Cancer Res. 1999. PMID: 10473115

6

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. Thalmann GN, et al. Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2). doi: 10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l. Prostate. 2000. PMID: 10881018

7

Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.

Wetterwald A, van der Pluijm G, Que I, Sijmons B, Buijs J, Karperien M, Löwik CW, Gautschi E, Thalmann GN, Cecchini MG. Wetterwald A, et al. Among authors: thalmann gn. Am J Pathol. 2002 Mar;160(3):1143-53. doi: 10.1016/S0002-9440(10)64934-6. Am J Pathol. 2002. PMID: 11891210 Free PMC article.

8

Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G, Löwik CW, Ackermann K, Pyerin W, Hamdy FC, Thalmann GN, Cecchini MG. Schwaninger R, et al. Among authors: thalmann gn. Am J Pathol. 2007 Jan;170(1):160-75. doi: 10.2353/ajpath.2007.051276. Am J Pathol. 2007. PMID: 17200191 Free PMC article.

9

Loss of inhibition over master pathways of bone mass regulation results in osteosclerotic bone metastases in prostate cancer.

Rentsch CA, Cecchini MG, Thalmann GN. Rentsch CA, et al. Among authors: thalmann gn. Swiss Med Wkly. 2009 Apr 18;139(15-16):220-5. doi: 10.4414/smw.2009.12284. Swiss Med Wkly. 2009. PMID: 19418305 Free article. Review.

10

Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.

Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF, Chung LW. Thalmann GN, et al. Eur Urol. 2010 Jul;58(1):162-71. doi: 10.1016/j.eururo.2009.08.026. Epub 2009 Sep 4. Eur Urol. 2010. PMID: 19747763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page